1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Israel Pharmaceuticals and Healthcare Report Q3 2016

Israel Pharmaceuticals and Healthcare Report Q3 2016

  • July 2016
  • -
  • Business Monitor International
  • -
  • 108 pages

Includes 3 FREE quarterly updates

BMI View: Israel will continue to be targeted by multinational drugmakers as a destination for innovativedrug sales; however, their relative success will be limited by funding constraints towards the country'shealth services basket and the lack of transparency with new drug inclusions. An uptick in economic growthand an increase to government funding supports our moderate growth outlook for Israel's pharmaceuticalsand healthcare sectors over the coming years.Headline Expenditure Projections

- Pharmaceuticals: ILS7.82bn (USD2.01bn) in 2015 to ILS8.14bn (USD2.10bn) in 2016; +4.1% in localcurrency terms and +4.4% in US dollar terms. Forecast in line with Q216.

- Healthcare: ILS89.56bn (USD23.05bn) in 2015 to ILS94.53bn (USD24.42bn) in 2016; +5.6% in localcurrency terms and +5.9% in US dollar terms. Forecast upgraded from Q216.

Table Of Contents

Israel Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Israel 2014-2020) 7
SWOT Analysis 9
SWOT 9
Industry Forecast 12
Pharmaceutical Market Forecast 12
Table: Pharmaceutical Sales, Historical Data And Forecasts (Israel 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Israel 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Israel 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Israel 2012-2020) 16
Prescription Drug Market Forecast 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Israel 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Israel 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Israel 2012-2020) 25
OTC Medicine Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Israel 2012-2020) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Israel 2014-2020) 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Israel 2014-2020) 30
Industry Risk/Reward Index 31
Middle East and Africa Risk/Reward Index - Q3 2016 31
Israel Risk/Reward Index 39
Rewards 39
Risks 39
Regulatory Review 41
Intellectual Property Issues 43
Pricing Regime 46
Table: Price Build-Up In The Israeli Pharmaceutical Market 47
Reimbursement Regime 47
Market Overview 52
Healthcare Sector 52
Table: Healthcare Resources (Israel 2010-2015) 59
Table: Healthcare Personnel (Israel 2010-2015) 59
Table: Healthcare Activity (Israel 2010-2015) 60
Research and Development 60
Table: Israel's RandD Legislation - Conditions For OCS Funding 62
Clinical Trials 62
Epidemiology 66
Competitive Landscape 69
Research-Based Industry 69
Table: Multinational Pharmaceutical Company Activity 72
Pharmaceutical Distribution 73
Pharmaceutical Retail Sector 73
Company Profile 74
Dexcel Pharma 74
Neopharm Group 77
Perrigo (Agis Industries) 80
Taro Pharmaceutical Industries 84
Teva Pharmaceutical Industries 88
Demographic Forecast 97
Table: Population Headline Indicators (Israel 1990-2025) 98
Table: Key Population Ratios (Israel 1990-2025) 99
Table: Urban/Rural Population and Life Expectancy (Israel 1990-2025) 99
Table: Population By Age Group (Israel 1990-2025) 100
Table: Population By Age Group % (Israel 1990-2025) 101
Glossary 102
Methodology 104
Pharmaceutical Expenditure Forecast Model 104
Healthcare Expenditure Forecast Model 104
Notes On Methodology 105
Risk/Reward Index Methodology 106
Index Overview 107
Table: Pharmaceutical Risk/Reward Index Indicators 107
Indicator Weightings 108

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.